Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Total Current Liabilities (2016 - 2026)

Eledon Pharmaceuticals filings provide 5 years of Total Current Liabilities readings, the most recent being $2.3 million for Q3 2017.

  • On a quarterly basis, Total Current Liabilities fell 63.65% to $2.3 million in Q3 2017 year-over-year; TTM through Sep 2017 was $2.3 million, a 63.65% decrease, with the full-year FY2016 number at $3.9 million, down 36.74% from a year prior.
  • Total Current Liabilities hit $2.3 million in Q3 2017 for Eledon Pharmaceuticals, down from $3.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $7.8 million in Q2 2016 to a low of $2.2 million in Q4 2013.
  • Median Total Current Liabilities over the past 5 years was $5.0 million (2014), compared with a mean of $4.7 million.
  • Biggest five-year swings in Total Current Liabilities: soared 92.08% in 2014 and later crashed 63.65% in 2017.
  • Eledon Pharmaceuticals' Total Current Liabilities stood at $2.2 million in 2013, then soared by 92.08% to $4.2 million in 2014, then soared by 45.23% to $6.2 million in 2015, then plummeted by 36.74% to $3.9 million in 2016, then plummeted by 40.84% to $2.3 million in 2017.
  • The last three reported values for Total Current Liabilities were $2.3 million (Q3 2017), $3.2 million (Q2 2017), and $2.4 million (Q1 2017) per Business Quant data.